This group included twelve patients: four NFU1 variants, three variants in MECP2, two patients with FOXF1 variants, one individual with an MMACHC variant, another one with a GBE1 variant, and one patient with Von Hippel-Lindau disease (VHL). This evidence concerns the gene GBE1 and von Hippel-Lindau disease.